Fosamax is a prescribed medication for adults having Paget Diseases. Fosamax falls into the category of Bisphosphonate drugs.
Fosamax is highly recommended for slowing down the bone loss and preventing other diseases related to bones.
Fosamax prevents bone fractures and increases bone mass. Fosamax is recommended for both men and women, who have been suffering from the traumas relating to bones.
Fosamax is used to treat the condition of thinning of bones in women after menopause and Osteoporosis in men.
Active Ingredient: Alendronate
Active Ingredients: Alendronate Sodium
Manufacturer: Merck & Sharp Dohme
License Holder: Merck Sharp & Dohme
Drug Class: Bisphosphonates
Pharmacological effect: Fosamax is a medication from the group of bisphosphonate. It slows the risk of bone loss and breakdown in the organism.
Usage: Fosamax is used in therapy and preventing of osteoporosis in menopausal women. It also cures the Paget’s disease of bone. This medicine maintains strong bones and decreases the fractures.
Aftereffect: Fosamax may bring abdominal pain and sickness in stomach. Call the doctor if you have the following adverse reactions: heartburn, pain in muscles, irritation of esophagus, troubled swallowing, skin irritation and problems with skin.
How to administer (optionally): Use it orally. Take it at least 30 minutes before breakfast. Take one tablet once a week.